ALUTARD SQ dermatophago pterony trait dép 4 x 5 ml

7680606910014 CH-60691 V01AA03 07.13.3.

Reimbursement limitations:

071330

Prise en charge seulement après exploration allergologique.

ALUTARD SQ dermatophago pterony trait dép 4 x 5 ml
ALUTARD SQ dermatophago pterony trait dép 4 x 5 ml
ALUTARD SQ dermatophago pterony trait dép 4 x 5 ml
1 / 3
google

Details

Product number
6069101
CPT
-
Packaging group
4 x 5 ml
Unit
Durchstechflasche(n)
Composition
A): acari allergeni extractum (dermatophagoides pteronyssinus) 100 U., aluminium ut aluminii hydroxidum hydricum ad adsorptionem, natrii hydroxidum, natrii chloridum, natrii hydrogenocarbonas, phenolum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml, natrium 2.64 mg/ml. B): acari allergeni extractum (dermatophagoides pteronyssinus) 1000 U., aluminium ut aluminii hydroxidum hydricum ad adsorptionem, natrii hydroxidum, natrii chloridum, natrii hydrogenocarbonas, phenolum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml, natrium 2.63 mg/ml. C): acari allergeni extractum (dermatophagoides pteronyssinus) 10'000 U., aluminium ut aluminii hydroxidum hydricum ad adsorptionem, natrii hydroxidum, natrii chloridum, natrii hydrogenocarbonas, phenolum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml, natrium 2.59 mg/ml. D): acari allergeni extractum (dermatophagoides pteronyssinus) 100'000 U., aluminium ut aluminii hydroxidum hydricum ad adsorptionem, natrii hydroxidum, natrii chloridum, natrii hydrogenocarbonas, phenolum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml, natrium 2.18 mg/ml.

Articles (1)

Alutard SQ Dermatophagoides pteronyssinus Kombipackung, Depotsuspension zur Injektion
Depotsuspension zur Injektion
4 x 5 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
21/02/2023
Professional SmPC
Français
21/02/2023
Professional SmPC
Italien
21/02/2023

Detailed composition

Substance Quantity Type Category
A
100.0 U Substance Wirkstoff (Principe actif)
D
- Substance Wirkstoff (Principe actif)
B
1000.0 U Substance Wirkstoff (Principe actif)
C
- Substance Wirkstoff (Principe actif)
B
- Substance HNIDK
D
- Substance HNIDK
A
- Substance HNIDK
C
- Substance HNIDK
C
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
D
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
D
- Substance HNIDK
C
- Substance HNIDK
D
- Substance HNIDK
C
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
D
- Substance HNIDK
C
- Substance HNIDK
D
- Substance Konservierungsstoff (Conservateur)
B
- Substance Konservierungsstoff (Conservateur)
A
- Substance Konservierungsstoff (Conservateur)
C
- Substance Konservierungsstoff (Conservateur)
D
- Substance HNIDK
B
- Substance HNIDK
C
- Substance HNIDK
A
- Substance HNIDK
D
2.18 MGML Substance HBESI
C
2.59 MGML Substance HBESI
A
2.64 MGML Substance HBESI
B
2.63 MGML Substance HBESI

Authorization holder

ALK-Abelló AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
60691
Drug name
Alutard SQ Dermatophagoides pteronyssinus, Depotsuspension zur Injektion
Galenic form
SUPA
ATC Code
V01AA03
Authorization status
Z
Dispensation category
A
First authorization
30/07/2010
Authorization expiration date
31/12/9999
IT number
07.13.3.
Domain
Human medicine
Field of application
Hyposensibilisierung

Packaging details

Description (FR)
ALUTARD SQ dermatophago pterony trait dép 4 x 5 ml
Description (DE)
ALUTARD SQ Dermatophago pterony Anf Be 4 x 5 ml
Market launch
30/07/2010
Narcotic (BTM)
No

Other packaging sizes

ALUTARD SQ-U dermatophago pterony trait cont 5 ml
1 x 5 ml DUR
View